[FONT=arial,helvetica]ELI LILLY & COMPANY [/FONT][FONT=arial,helvetica][/FONT][FONT=arial,helvetica]Secure supply of pork-based insulin welcomed[/FONT] [FONT=arial,helvetica]2/13/06 [/FONT] Canadian Diabetes Association and Society for Diabetic Rights welcome new supplier TORONTO, Feb. 13, 2006 (Canada NewsWire via COMTEX) -- The Canadian Diabetes Association welcomes the announcement that Canadians who rely on pork-based insulin to stay alive each day will continue to be able to buy the medication they need. The Canadian Diabetes Association, along with the Vancouver-based Society for Diabetic Rights, is pleased Health Canada has reached agreement with Britain's Wochardt UK Limited to supply two pork-based insulin formulations to the Canadian market in time for the April 1st discontinuation deadline set by Canada's lone current supplier of pork insulin, Eli Lilly and Company. "The Canadian Diabetes Association strongly advocates that people who are dependent on a treatment option that is approved for use in Canada - in this case pork insulin - should continue to have easy access to that treatment," said Karen Philp, National Director Public Policy and Government Relations, Canadian Diabetes Association. On July 6, 2005, Eli Lilly and Company announced it would cease manufacturing both its pork-based insulins: Iletin II Regular and Iletin II NPH pork insulin. Eli Lilly is the only remaining provider of pork insulin in Canada. Supplies of both formulations were expected to be available until April 1, 2006. Lilly Canada has been working with Health Canada and Wockhardt UK Limited to permit its two insulin formulations to be approved for sale in Canada. On January 24, 2006, Health Canada granted Wockhardt UK Ltd. authorization to market its pork insulins, Hypurin Regular and Hypurin NPH, in Canada. "We are very happy and relieved that Health Canada has approved Wockhardt's pork insulin for Canadians who want or need it. This is in line with Health Canada's acknowledgement that some people need animal insulin to manage their diabetes," said Colleen Fuller, Co-chair of the Society for Diabetic Rights. "We now will want to work for a national strategy to raise awareness among health professionals as well as people with diabetes that Wockhardt's pork insulin is, in fact, available for these Canadians." More than two million Canadians have diabetes and this number is expected to increase dramatically as the population ages. Risk factors for type 2 diabetes include being age 40 and over, being related to a person with diabetes, being of Aboriginal, Hispanic, South Asian, Asian or African descent, and being overweight or obese. The Canadian Diabetes Association works to prevent diabetes and improve the quality of life for those affected, through research, education, service and advocacy. With a presence in more than 150 communities, the Canadian Diabetes Association's strong network of assistance includes volunteers, employees, healthcare professionals and partners. The Canadian Diabetes Association - Know who to turn to. The Society for Diabetic Rights was formed in 2001 to work for a strategy to retain natural animal insulins in Canada. The members work as volunteers to inform physicians and people with diabetes about the problems they and others experience with recombinant or biosynthetic human insulin. Their goal is to see a national strategy in Canada to ensure a secure, affordable and domestically-accessible source of natural animal insulin, both beef and pork. SOURCE: Canadian Diabetes Association please contact: Jan Johnson, Manager, Marketing & Communications, Prairies, (306 584-8445 extn.227, firstname.lastname@example.org Copyright (C) 2006 CNW Group. All rights reserved.